Skip to content
Disclosery

EXANE DERIVATIVES: MRK position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on MRK, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 64,879 MRK shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 64,879 shares
    Change vs previous 13F -3,015 shares

    3.4% of the 13F portfolio, value $5,914,298.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 67,894 shares
    Change vs previous 13F +10,456 shares

    1.57% of the 13F portfolio, value $5,570,741.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 57,438 shares
    Change vs previous 13F -4,987 shares

    1.07% of the 13F portfolio, value $4,402,190.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 62,425 shares
    Change vs previous 13F +8,947 shares

    1.17% of the 13F portfolio, value $4,688,927.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 53,478 shares
    Change vs previous 13F +2,036 shares

    0.97% of the 13F portfolio, value $4,150,520.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 51,442 shares
    Change vs previous 13F +3,806 shares

    1.19% of the 13F portfolio, value $3,965,847.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 47,636 shares
    Change vs previous 13F -27,043 shares

    1.18% of the 13F portfolio, value $3,896,797.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 74,679 shares
    Change vs previous 13F not available

    2.02% of the 13F portfolio, value $6,194,790.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).